Board of Trustees of The Leland Stanford Junior University’s BeOne Medicines Ltd ONC Stock Holding History

Board of Trustees of The Leland Stanford Junior University’s Portfolio ONC Stock Details ONC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-50,000	Closed	-$1.52M	–	25
2016 Q4	$1.52M	Hold	50,000	–	–	0.18%	10
2016 Q3	$1.54M	Hold	50,000	–	–	0.17%	8
2016 Q2	$1.49M	Hold	50,000	–	–	0.2%	7
2016 Q1	$1.47M	Buy	+50,000	New	+$1.42M	0.2%	9

Other funds holding ONC

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

HIM

Hillhouse Investment Management Grand Cayman, Cayman Islands $3.13B AUM 7.29% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Board of Trustees of The Leland Stanford Junior University's ONC Position: Q1 2017 in Review

Board of Trustees of The Leland Stanford Junior University sold out of BeOne Medicines Ltd (ONC) in Q1 2017, closing a stake of 50,000 shares — an estimated $1.52M sold.

Board of Trustees of The Leland Stanford Junior University first reported a position in ONC in Q1 2016 and held it in 4 quarters. The position peaked at $1.54M in Q3 2016. 56 funds tracked by Wall St. Rank hold ONC as of Q1 2017.

Board of Trustees of The Leland Stanford Junior University reported no remaining BeOne Medicines Ltd position as of Q1 2017 after selling out during the quarter.
Board of Trustees of The Leland Stanford Junior University sold 50,000 BeOne Medicines Ltd shares in Q1 2017, an estimated $1.52M.
Board of Trustees of The Leland Stanford Junior University first reported a position in BeOne Medicines Ltd in Q1 2016 and held it in 4 quarters.
Board of Trustees of The Leland Stanford Junior University's BeOne Medicines Ltd position peaked at $1.54M in Q3 2016.
56 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q1 2017.

Based on Board of Trustees of The Leland Stanford Junior University's 13F filing for Q1 2017, filed 12 May 2017.